Learned risk-taking behaviours can persist for years after leaving the lab — and even after taking on a new research topic.

Virax Biolabs Group Limited (VRAX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Although the revenue and EPS for BlackRock (BLK) give a sense of how its business performed in the quarter ended December ...